Changes in plasma mullerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women

被引：6
作者：
Aslam, Muhammad Faisal [1 ]
Merhi, Zaher O. [2 ]
Ahmed, Safaa [1 ]
Kuzbari, Oumar [1 ]
Seifer, David B. [1 ]
Minkoff, Howard [1 ]
机构：
[1] Maimonides Hosp, Dept Obstet & Gynecol, Brooklyn, NY 11219 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Div Reprod Endocrinol & Infertil, Bronx, NY 10467 USA
来源：
FERTILITY AND STERILITY | 2011年 / 95卷 / 05期
关键词：
Anti-mullerian hormone; brain-derived neurotrophic factor; cancer; chemotherapy; mullerian-inhibiting substance; ovarian reserve; ASSISTED REPRODUCTIVE TECHNOLOGY; CHILDHOOD-CANCER SURVIVORS; OVARIAN RESERVE; BREAST-CANCER; FOLLICULAR-FLUID; MENSTRUAL CYCLES; HUMAN PLATELETS; NERVOUS-SYSTEM; HORMONE; EXPRESSION;
D O I：
10.1016/j.fertnstert.2010.10.033
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Eight premenopausal women with cancer had blood drawn for analysis of brain-derived neurotrophic factor (BDNF) and mullerian-inhibiting substance (MIS) before and 3 months after receiving chemotherapy. Unlike MIS, BDNF levels were not reduced after chemotherapy. (Fertil Steril (R) 2011; 95: 1790-3. (C) 2011 by American Society for Reproductive Medicine.)
引用
收藏
页码：1790 / 1793
页数：4
相关论文
共 29 条
[1]   The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer [J].
Anderson, R. A. ;
Themmen, A. P. N. ;
Al-Qahtani, A. ;
Groome, N. P. ;
Cameron, D. A. .
HUMAN REPRODUCTION, 2006, 21 (10) :2583-2592
[2]   ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN RAT OVARIES DURING POSTNATAL-DEVELOPMENT, THE ESTROUS-CYCLE, AND GONADOTROPIN-INDUCED FOLLICLE GROWTH [J].
BAARENDS, WM ;
UILENBROEK, JTJ ;
KRAMER, P ;
HOOGERBRUGGE, JW ;
VANLEEUWEN, ECM ;
THEMMEN, APN ;
GROOTEGOED, JA .
ENDOCRINOLOGY, 1995, 136 (11) :4951-4962
[3]   Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound [J].
Bath, LE ;
Wallace, WHB ;
Shaw, MP ;
Fitzpatrick, C ;
Anderson, RA .
HUMAN REPRODUCTION, 2003, 18 (11) :2368-2374
[4]   Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor [J].
Begliuomini, S. ;
Casarosa, E. ;
Pluchino, N. ;
Lenzi, E. ;
Centofanti, M. ;
Freschi, L. ;
Pieri, M. ;
Genazzani, A. D. ;
Luisi, S. ;
Genazzani, Andrea R. .
HUMAN REPRODUCTION, 2007, 22 (04) :995-1002
[5]   Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer [J].
Bines, J ;
Oleske, DM ;
Cobleigh, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1718-1729
[6]   Follicular-fluid neurotrophin levels in women undergoing assisted reproductive technology for different etiologies of infertility [J].
Buyuk, Erkan ;
Seifer, David B. .
FERTILITY AND STERILITY, 2008, 90 (05) :1611-1615
[7]   Antimullerian hormone serum levels: a putative marker for ovarian aging [J].
de Vet, A ;
Laven, JSE ;
de Jong, FH ;
Themmen, APN ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2002, 77 (02) :357-362
[8]   Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results [J].
Decanter, Christine ;
Morschhauser, Franck ;
Pigny, Pascal ;
Lefebvre, Catherine ;
Gallo, Cecile ;
Dewailly, Didier .
REPRODUCTIVE BIOMEDICINE ONLINE, 2010, 20 (02) :280-285
[9]   Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone [J].
Fong, S. Lie ;
Laven, J. S. E. ;
Hakvoort-Cammel, F. G. A. J. ;
Schipper, I. ;
Visser, J. A. ;
Themmen, A. P. N. ;
de Jong, F. H. ;
van den Heuvel-Eibrink, M. M. .
HUMAN REPRODUCTION, 2009, 24 (04) :982-990
[10]   Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/I [J].
Larsen, EC ;
Müller, J ;
Rechnitzer, C ;
Schmiegelow, K ;
Andersen, AN .
HUMAN REPRODUCTION, 2003, 18 (02) :417-422
123